Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
5
Ṁ160Ṁ422028
58%
chance
1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Market context
Get
1,000 to start trading!
People are also trading
Related questions
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
86% chance
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will ANY of {metformin, canagliflozin, acarbose, rapamycin} be made OTC to purchase in US by Jan2028?
48% chance
Will jurgen schmidhuber end up taking rapamycin by EOY 2028
41% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Will Jose Luis ricon finally start regularly taking rapamycin by 2030?
45% chance